Hostname: page-component-8448b6f56d-t5pn6 Total loading time: 0 Render date: 2024-04-25T01:50:26.964Z Has data issue: false hasContentIssue false
  • English
  • Français

Comparative risk of self-harm hospitalization amongst depressive disorder patients using different antidepressants: a population-based cohort study in Taiwan

Published online by Cambridge University Press:  23 September 2016

C.-S. Wu ,
S.-C. Liao ,
Y.-T. Tsai ,
S.-S. Chang  and
H.-J. Tsai
C.-S. Wu
Affiliation:
Department of Psychiatry, National Taiwan University Hospital and College of Medicine, National Taiwan University, Taipei, Taiwan Department of Psychiatry, Far Eastern Memorial Hospital, New Taipei City, Taiwan
S.-C. Liao
Affiliation:
Department of Psychiatry, National Taiwan University Hospital and College of Medicine, National Taiwan University, Taipei, Taiwan
Y.-T. Tsai
Affiliation:
Division of Biostatistics and Bioinformatics, Institute of Population Health Sciences, National Health Research Institutes, Zhunan, Taiwan
S.-S. Chang*
Affiliation:
Institute of Health Behaviors and Community Sciences and Department of Public Health, College of Public Health, National Taiwan University, Taipei, Taiwan
H.-J. Tsai*
Affiliation:
Division of Biostatistics and Bioinformatics, Institute of Population Health Sciences, National Health Research Institutes, Zhunan, Taiwan Department of Public Health, China Medical University, Taichung, Taiwan Department of Pediatrics, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA
*
*Addresses for correspondence: H.-J. Tsai, Division of Biostatistics and Bioinformatics, Institute of Population Health Sciences, National Health Research Institutes, 35 Keyan Road, Zhunan Town, Miaoli County 350, Taiwan; S.-S. Chang, Institute of Health Behaviors and Community Sciences and Department of Public Health, College of Public Health, National Taiwan University, Room 623, No.17, Xu-Zhou Road, Zhongzheng Dist., Taipei City 10055, Taiwan. (Email: tsaihj@nhri.org.tw and h-tsai@northwestern.edu) [H.-J.T] (Email: shusen.chang@gmail.com) [S.-S.C.]
*Addresses for correspondence: H.-J. Tsai, Division of Biostatistics and Bioinformatics, Institute of Population Health Sciences, National Health Research Institutes, 35 Keyan Road, Zhunan Town, Miaoli County 350, Taiwan; S.-S. Chang, Institute of Health Behaviors and Community Sciences and Department of Public Health, College of Public Health, National Taiwan University, Room 623, No.17, Xu-Zhou Road, Zhongzheng Dist., Taipei City 10055, Taiwan. (Email: tsaihj@nhri.org.tw and h-tsai@northwestern.edu) [H.-J.T] (Email: shusen.chang@gmail.com) [S.-S.C.]
Get access Rights & Permissions [Opens in a new window]

Abstract

Background

The aim of the study was to evaluate the comparative risk of self-harm associated with the use of different antidepressants.

Method

A cohort study was conducted using data from Taiwan's National Health Insurance Research Database from 2001 to 2012. A total of 751 606 new antidepressant users with depressive disorders were included. The study outcome was hospitalization due to self-harm (International Classification of Diseases, Ninth Revision, Clinical Modification codes: E950–E958 and E980–E988). Cox proportional hazards models with stratification of the propensity score deciles were used to estimate the hazard ratios of self-harm hospitalization during the first year following the initiation of antidepressant treatment.

Results

There were 1038 hospitalization episodes due to self-harm that occurred during the follow-up of 149 796 person-years, with an overall incidence rate of 6.9 [95% confidence interval (CI) 6.5–7.4] per 1000. Compared with fluoxetine, the risk of self-harm hospitalization was higher for maprotiline [adjusted hazard ratio (aHR) = 3.00, 95% CI 1.40–6.45], milnacipran (aHR = 2.34, 95% CI 1.24–4.43) and mirtazapine (aHR = 1.40, 95% CI 1.06–1.86), lower for bupropion (aHR = 0.51, 95% CI 0.30–0.86), and similar level of risk was found for other selective serotonin reuptake inhibitors (citalopram, escitalopram, fluvoxamine, paroxetine and sertraline).

Conclusions

The risk of self-harm may vary across different antidepressant drugs. It would be of importance to conduct further research to investigate the influence of antidepressant use on self-harm behaviors.

Keywords

Antidepressantsdepressive disorderself-harm
Type
Original Articles
Information
Psychological Medicine , Volume 47 , Issue 1 , January 2017 , pp. 81 - 92
Copyright
Copyright © Cambridge University Press 2016 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Barbui, C, Esposito, E, Cipriani, A (2009). Selective serotonin reuptake inhibitors and risk of suicide: a systematic review of observational studies. CMAJ: Canadian Medical Association Journal 180, 291–297.Google Scholar
Cepeda, MS, Boston, R, Farrar, JT, Strom, BL (2003). Comparison of logistic regression v. propensity score when the number of events is low and there are multiple confounders. American Journal of Epidemiology 158, 280–287.Google Scholar
Chang, SS, Sterne, JA, Lu, TH, Gunnell, D (2010). ‘Hidden’ suicides amongst deaths certified as undetermined intent, accident by pesticide poisoning and accident by suffocation in Taiwan. Social Psychiatry and Psychiatric Epidemiology 45, 143–152.Google Scholar
Cheung, K, Aarts, N, Noordam, R, van Blijderveen, JC, Sturkenboom, MC, Ruiter, R, Visser, LE, Stricker, BH (2015). Antidepressant use and the risk of suicide: a population-based cohort study. Journal of Affective Disorders 174, 479–484.CrossRefGoogle ScholarPubMed
Cooper, WO, Callahan, ST, Shintani, A, Fuchs, DC, Shelton, RC, Dudley, JA, Graves, AJ, Ray, WA (2014). Antidepressants and suicide attempts in children. Pediatrics 133, 204–210.Google Scholar
Coupland, C, Hill, T, Morriss, R, Arthur, A, Moore, M, Hippisley-Cox, J (2015). Antidepressant use and risk of suicide and attempted suicide or self harm in people aged 20 to 64: cohort study using a primary care database. British Medical Journal 350, h517.Google Scholar
Fergusson, D, Doucette, S, Glass, KC, Shapiro, S, Healy, D, Hebert, P, Hutton, B (2005). Association between suicide attempts and selective serotonin reuptake inhibitors: systematic review of randomised controlled trials. British Medical Journal 330, 396.Google Scholar
Gibbons, RD, Coca Perraillon, M, Hur, K, Conti, RM, Valuck, RJ, Brent, DA (2015). Antidepressant treatment and suicide attempts and self-inflicted injury in children and adolescents. Pharmacoepidemiology and Drug Safety 24, 208–214.Google Scholar
Gorton, HC, Webb, RT, Kapur, N, Ashcroft, DM (2016). Non-psychotropic medication and risk of suicide or attempted suicide: a systematic review. BMJ Open 6, e009074.Google Scholar
Hammad, TA, Laughren, T, Racoosin, J (2006). Suicidality in pediatric patients treated with antidepressant drugs. Archives of General Psychiatry 63, 332–339.Google Scholar
Harris, EC, Barraclough, B (1997). Suicide as an outcome for mental disorders. A meta-analysis. British Journal of Psychiatry 170, 205–228.Google Scholar
Hawton, K, van Heeringen, K (2009). Suicide. Lancet 373, 1372–1381.Google Scholar
Isacsson, G, Holmgren, P, Ahlner, J (2005). Selective serotonin reuptake inhibitor antidepressants and the risk of suicide: a controlled forensic database study of 14 857 suicides. Acta Psychiatrica Scandinavica 111, 286–290.Google Scholar
Jick, H, Kaye, JA, Jick, SS (2004). Antidepressants and the risk of suicidal behaviors. Journal of the American Medical Association 292, 338–343.Google Scholar
Libby, AM, Brent, DA, Morrato, EH, Orton, HD, Allen, R, Valuck, RJ (2007). Decline in treatment of pediatric depression after FDA advisory on risk of suicidality with SSRIs. American Journal of Psychiatry 164, 884–891.CrossRefGoogle ScholarPubMed
Lu, CY, Zhang, F, Lakoma, MD, Madden, JM, Rusinak, D, Penfold, RB, Simon, G, Ahmedani, BK, Clarke, G, Hunkeler, EM, Waitzfelder, B, Owen-Smith, A, Raebel, MA, Rossom, R, Coleman, KJ, Copeland, LA, Soumerai, SB (2014). Changes in antidepressant use by young people and suicidal behavior after FDA warnings and media coverage: quasi-experimental study. British Medical Journal 348, g3596.Google Scholar
Lu, TH (2012). Using National Health Insurance claims data to establish injury surveillance in Taiwan. Injury Prevention 18, A233–A233.Google Scholar
Martinez, C, Rietbrock, S, Wise, L, Ashby, D, Chick, J, Moseley, J, Evans, S, Gunnell, D (2005). Antidepressant treatment and the risk of fatal and non-fatal self harm in first episode depression: nested case–control study. British Medical Journal 330, 389.CrossRefGoogle ScholarPubMed
Miller, M, Pate, V, Swanson, SA, Azrael, D, White, A, Sturmer, T (2014). Antidepressant class, age, and the risk of deliberate self-harm: a propensity score matched cohort study of SSRI and SNRI users in the USA. CNS Drugs 28, 79–88.CrossRefGoogle ScholarPubMed
Olfson, M, Marcus, SC, Shaffer, D (2006). Antidepressant drug therapy and suicide in severely depressed children and adults: a case–control study. Archives of General Psychiatry 63, 865–872.Google Scholar
Rihmer, Z (2007). Suicide risk in mood disorders. Current Opinion in Psychiatry 20, 17–22.Google Scholar
Robertson, HT, Allison, DB (2009). Drugs associated with more suicidal ideations are also associated with more suicide attempts. PLoS ONE 4, e7312.Google Scholar
Rubino, A, Roskell, N, Tennis, P, Mines, D, Weich, S, Andrews, E (2007). Risk of suicide during treatment with venlafaxine, citalopram, fluoxetine, and dothiepin: retrospective cohort study. British Medical Journal 334, 242.Google Scholar
Schneeweiss, S, Patrick, AR, Solomon, DH, Dormuth, CR, Miller, M, Mehta, J, Lee, JC, Wang, PS (2010 a). Comparative safety of antidepressant agents for children and adolescents regarding suicidal acts. Pediatrics 125, 876–888.Google Scholar
Schneeweiss, S, Patrick, AR, Solomon, DH, Mehta, J, Dormuth, C, Miller, M, Lee, JC, Wang, PS (2010 b). Variation in the risk of suicide attempts and completed suicides by antidepressant agent in adults: a propensity score-adjusted analysis of 9 years’ data. Archives of General Psychiatry 67, 497–506.Google Scholar
Shih, HI, Lin, MC, Lin, CC, Hsu, HC, Lee, HL, Chi, CH, Sung, FC, Chang, YJ, Kao, CH (2013). Benzodiazepine therapy in psychiatric outpatients is associated with deliberate self-poisoning events at emergency departments – a population-based nested case–control study. Psychopharmacology (Berlin) 229, 665–671.Google Scholar
Sondergard, L, Lopez, AG, Andersen, PK, Kessing, LV (2007). Continued antidepressant treatment and suicide in patients with depressive disorder. Archives of Suicide Research 11, 163–175.Google Scholar
Stone, M, Laughren, T, Jones, ML, Levenson, M, Holland, PC, Hughes, A, Hammad, TA, Temple, R, Rochester, G (2009). Risk of suicidality in clinical trials of antidepressants in adults: analysis of proprietary data submitted to US Food and Drug Administration. British Medical Journal 339, b2880.Google Scholar
Stone, MB (2014). The FDA warning on antidepressants and suicidality – why the controversy? New England Journal of Medicine 371, 1668–1671.Google Scholar
Thomas, KH, Martin, RM, Davies, NM, Metcalfe, C, Windmeijer, F, Gunnell, D (2013). Smoking cessation treatment and risk of depression, suicide, and self harm in the Clinical Practice Research Datalink: prospective cohort study. British Medical Journal 347, f5704.Google Scholar
Tiihonen, J, Lonnqvist, J, Wahlbeck, K, Klaukka, T, Tanskanen, A, Haukka, J (2006). Antidepressants and the risk of suicide, attempted suicide, and overall mortality in a nationwide cohort. Archives of General Psychiatry 63, 1358–1367.Google Scholar
Valenstein, M, Kim, HM, Ganoczy, D, Eisenberg, D, Pfeiffer, PN, Downing, K, Hoggatt, K, Ilgen, M, Austin, KL, Zivin, K, Blow, FC, McCarthy, JF (2012). Antidepressant agents and suicide death among US Department of Veterans Affairs patients in depression treatment. Journal of Clinical Psychopharmacology 32, 346–353.Google Scholar
Valuck, RJ, Libby, AM, Orton, HD, Morrato, EH, Allen, R, Baldessarini, RJ (2007). Spillover effects on treatment of adult depression in primary care after FDA advisory on risk of pediatric suicidality with SSRIs. American Journal of Psychiatry 164, 1198–1205.CrossRefGoogle ScholarPubMed
Valuck, RJ, Libby, AM, Sills, MR, Giese, AA, Allen, RR (2004). Antidepressant treatment and risk of suicide attempt by adolescents with major depressive disorder: a propensity-adjusted retrospective cohort study. CNS Drugs 18, 1119–1132.Google Scholar
Valuck, RJ, Orton, HD, Libby, AM (2009). Antidepressant discontinuation and risk of suicide attempt: a retrospective, nested case–control study. Journal of Clinical Psychiatry 70, 1069–1077.Google Scholar
WHO Collaborating Centre for Drug Statistic Methodology (2009). WHO Collaborating Centre for Drug Statistic Methodology: Guidelines for ATC Classification and DDD Assignment. WHO: Oslo.Google Scholar
Wightman, DS, Foster, VJ, Krishen, A, Richard, NE, Modell, JG (2010). Meta-analysis of suicidality in placebo-controlled clinical trials of adults taking bupropion. Primary Care Companion to the Journal of Clinical Psychiatry 12, PCC.09m00894.Google Scholar
Wu, CS, Shau, WY, Chan, HY, Lee, YC, Lai, YJ, Lai, MS (2012). Utilization of antidepressants in Taiwan: a nationwide population-based survey from 2000 to 2009. Pharmacoepidemiology and Drug Safety 21, 980–988.Google Scholar
Supplementary material: File

Wu supplementary material

Tables S1-S5

Download Wu supplementary material(File)
File 440.3 KB
Supplementary material: Image

Wu supplementary material

Figure S1

Download Wu supplementary material(Image)
Image 219.4 KB